Samuel J Stellpflug

2 papers in the library · 92 citations · publishing 2013-2014

Papers

Sort Most recent Most cited

2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing.

Journal of Medical Toxicology March 1, 2014 Samuel J Stellpflug, Samantha E Kealey, Cullen B Hegarty et al. 92 citations

2C designer drugs have been in use since the 1970s, but new drugs continue to develop from substitutions to the base phenethylamine structure. This creates new clinical profiles and difficulty with laboratory confirmation. 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) is a relatively new 2C drug that is more potent than structural 2C analogs; exposure reports...

DOI: 10.1007/s13181-013-0314-y Full text Designer drugs New psychoactive substances Nps Synthetic drugs +19

2C or not 2C: phenethylamine designer drug review.

Journal of Medical Toxicology June 2013 Be Vang Dean, Samuel J Stellpflug, Aaron M Burnett et al.

New groups of synthetic "designer drugs" have increased in popularity over the past several years. These products mimic the euphoric effects of other well-known illicit drugs but are advertised as "legal" highs and are sold over the internet, at raves and night clubs, and in head shops. The 2C series drugs are ring-substituted phenethylamines that belong to a group of designer agents similar in...

DOI: 10.1007/s13181-013-0295-x Full text